Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Bakhu Holdings, Corp. (BKUH)
USD0.00
+0.00 (+0.00%)
US OTC Healthcare Drug Manufacturers - Specialty & Generic
Address
One World Trade Center 90831
Long Beach, CA, US
Long Beach, CA, US
CEO
Teddy C. Scott
Website
bakhuholdings.com
IPO
2018-02-13
CIK 1440153 ISIN US0575862083
Description
Headquartered in Long Beach, California, Bakhu Holdings, Corp. was established in 2008. This company specializes in the creation, manufacturing, and sale of cannabis-derived products, catering to medical, food additive, and recreational markets throughout the United States and the Caribbean. It operated as Planet Resources, Corp. until May 2009, when it adopted its current name.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.00
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
6
Beta
2.41
Float Shares
101.83M
Free Float %
33.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | -95.00% | -95.00% | -95.00% | -93.33% | -99.91% | -99.96% | -99.93% | -99.93% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.00
Quality scores
Altman Z-Score
-134.56
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
1 / 10
No MOAT
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%—
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%+33.5% ★ Q2'24: +70.0% (vs Q2'23)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%—
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%—
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%— Q2'24: +156.9% (vs Q2'23)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%+0.1% Q2'24: +0.0% (vs Q2'23)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×-0.68× Q2'24: -2.62× (vs Q2'23)
Valuation Multiples
From
To
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
2
Beneficial owners (>5%)
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.67
Neutral
Ratio by volume
1.79
Bullish
Buys
6
Sells
9
Shares acquired
1.07M
Shares disposed
600.0K
Cash buys
—
Cash sales
—
Net activity
+472,890
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-29 | Scott Teddy JR | Director / Officer | — | D | Stock Option | 240,000 | 1.00 | 240.0K | 0 | — | ↗ |
| 2024-03-14 | Popolizio Aristotle | Director / Officer | I-Discretionary | A | Common Stock | 2,500,000 | 0.00 | — | 2,626,882 | — | ↗ |
| 2024-03-05 | Popolizio Aristotle | Director / Officer | I-Discretionary | D | Stock Option | 700,000 | 2.60 | 1.82M | 240,000 | — | ↗ |
| 2024-02-29 | Whitton Peter | Director / 10% Owner | A-Award | A | Common Stock | 240,000 | 1.00 | 240.0K | 340,000 | — | ↗ |
| 2024-02-29 | Popolizio Aristotle | Director / Officer | A-Award | A | Stock Option | 240,000 | 1.00 | 240.0K | 240,000 | — | ↗ |
| 2024-02-29 | Garcia La Sienra Garcia Juan Carlos | Director / Officer | A-Award | A | Stock Option | 240,000 | 1.00 | 240.0K | 540,000 | — | ↗ |
| 2023-09-18 | Whitton Peter | Director / 10% Owner | I-Discretionary | A | Series A Preferred | 4 | 0.00 | — | 0 | — | ↗ |
| 2023-07-31 | Whitton Peter | Director / 10% Owner | — | I | Series A Preferred | 0 | 0.00 | — | 4 | — | ↗ |
| 2023-07-31 | Popolizio Aristotle | Director / Officer | — | D | Stock Option | 0 | 0.00 | — | 126,882 | — | ↗ |
| 2023-07-31 | Garcia La Sienra Garcia Juan Carlos | Director / Officer / 10% Owner | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-08-18 | Inter-M Traders FZ, LLE | Director | G-Gift | A | Stock Option | 216,445 | 0.00 | — | 116,783,555 | — | ↗ |
| 2022-07-31 | Whitton Peter | Director / 10% Owner | — | I | Series A Preferred Stock | 0 | 0.00 | — | 4 | — | ↗ |
| 2022-07-31 | Vaknin Tom | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-07-31 | Rozen Sagi Rami | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-07-31 | Popolizio Aristotle | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 126,882 | — | ↗ |
| 2022-07-31 | Morgenstern Moshe | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-07-31 | Mentone, Ltd. | 10% Owner | — | I | Series A Preferred Stock | 0 | 0.00 | — | 4 | — | ↗ |
| 2022-07-31 | Inter-M Traders FZ, LLE | 10% Owner | — | I | Series A Preferred Stock | 0 | 0.00 | — | 4 | — | ↗ |
| 2022-07-31 | HAWTHORNE MICHAEL RICHARD | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-07-31 | Garcia La Sienra Garcia Juan Carlos | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-07-31 | Drakos Evripides | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 126,882 | — | ↗ |
| 2022-07-31 | Dixon Geoffrey Robert | 10% Owner | — | I | Series A Preferred Stock | 0 | 0.00 | — | 4 | — | ↗ |
| 2022-07-31 | Cell Science Holding, Ltd. | 10% Owner | — | D | Series A Preferred Stock | 0 | 0.00 | — | 4 | — | ↗ |
| 2022-07-29 | Vaknin Tom | Director | — | D | Stock Option | 300,000 | 1.50 | 450.0K | 0 | — | ↗ |
| 2022-07-29 | Rozen Sagi Rami | Director | A-Award | A | Stock Option | 160,000 | 1.50 | 240.0K | 300,000 | — | ↗ |
| 2022-07-29 | Morgenstern Moshe | Director | — | D | Stock Option | 300,000 | 1.50 | 450.0K | 0 | — | ↗ |
| 2022-07-29 | Garcia La Sienra Garcia Juan Carlos | Director | A-Award | A | Stock Option | 160,000 | 1.50 | 240.0K | 300,000 | — | ↗ |
| 2022-05-31 | Whitton Peter | Director | G-Gift | A | Common Stock | 3,000,000 | 0.00 | — | 24,160,007 | — | ↗ |
| 2022-05-31 | Mentone, Ltd. | Director | G-Gift | A | com | 20,952,187 | 0.00 | — | 6,000,000 | — | ↗ |
| 2022-05-31 | Dixon Geoffrey Robert | Director | X-InTheMoney | A | Common Stock | 3,000,000 | 0.00 | — | 23,952,188 | — | ↗ |
| 2022-04-18 | Popolizio Aristotle | Officer | A-Award | A | Stock Option | 1,300,000 | 3.30 | 4.29M | 2,100,000 | — | ↗ |
| 2022-04-18 | Drakos Evripides | Officer | A-Award | A | Stock Option | 1,300,000 | 3.30 | 4.29M | 2,100,000 | — | ↗ |
| 2022-03-03 | Whitton Peter | Director | G-Gift | A | Common Stock | 27,033,125 | 0.00 | — | 27,160,007 | — | ↗ |
| 2022-03-03 | Mentone, Ltd. | Director | Z-Trust | D | Common Stock | 60,547,813 | 0.00 | — | 26,952,187 | — | ↗ |
| 2022-03-03 | Dixon Geoffrey Robert | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 26,952,188 | — | ↗ |
| 2022-02-28 | HAWTHORNE MICHAEL RICHARD | Officer | — | D | Stock Option | 2,000,000 | 3.00 | 6.00M | 0 | — | ↗ |
| 2022-01-05 | Popolizio Aristotle | Director / Officer | A-Award | A | Stock Option | 700,000 | 2.60 | 1.82M | 800,000 | — | ↗ |
| 2022-01-05 | Drakos Evripides | Director / Officer | A-Award | A | Stock Option | 700,000 | 2.60 | 1.82M | 800,000 | — | ↗ |
| 2021-12-06 | Garcia La Sienra Garcia Juan Carlos | Director / Officer | — | D | Stock Option | 300,000 | 3.40 | 1.02M | 0 | — | ↗ |
| 2021-12-03 | Rozen Sagi Rami | Director | — | D | Stock Option | 300,000 | 3.40 | 1.02M | 0 | — | ↗ |
| 2021-09-22 | Whitton Peter | Director / 10% Owner | S-Sale | A | Common Stock | 71,429 | 0.00 | — | 87,626,882 | — | ↗ |
| 2021-09-22 | Mentone, Ltd. | 10% Owner | S-Sale | A | Common Stock | 71,429 | 0.00 | — | 87,500,000 | — | ↗ |
| 2021-09-22 | Inter-M Traders FZ, LLE | 10% Owner | S-Sale | A | Common Stock | 5,571,429 | 0.00 | — | 117,000,000 | — | ↗ |
| 2021-09-16 | Scott Teddy JR | Director / Officer | — | D | Stock Option | 718,085 | 4.50 | 3.23M | 0 | — | ↗ |
| 2021-07-31 | Whitton Peter | Director / 10% Owner | — | I | Series A Preferred Stock | 0 | 0.00 | — | 4 | — | ↗ |
| 2021-07-31 | Popolizio Aristotle | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 126,882 | — | ↗ |
| 2021-07-31 | Mentone, Ltd. | 10% Owner | — | I | Series A Preferred Stock | 0 | 0.00 | — | 4 | — | ↗ |
| 2021-07-31 | Inter-M Traders FZ, LLE | 10% Owner | — | I | Series A Preferred Stock | 0 | 0.00 | — | 4 | — | ↗ |
| 2021-07-31 | Emmitt Thomas K | — | — | D | Common Stock | 0 | 0.00 | — | 115,000 | — | ↗ |
| 2021-07-31 | Drakos Evripides | Director | — | D | Common Stock | 0 | 0.00 | — | 126,882 | — | ↗ |
| 2021-07-31 | Cell Science Holding, Ltd. | 10% Owner | — | D | Series A Preferred Stock | 0 | 0.00 | — | 4 | — | ↗ |
| 2021-04-27 | Whitton Peter | Director | X-InTheMoney | A | Common Stock | 126,882 | 5.10 | 647.1K | 87,555,453 | — | ↗ |
| 2021-04-27 | Popolizio Aristotle | Director / Officer | X-InTheMoney | A | Common Stock | 126,882 | 5.10 | 647.1K | 126,882 | — | ↗ |
| 2021-04-27 | Drakos Evripides | Director | X-InTheMoney | A | Common Stock | 126,882 | 5.10 | 647.1K | 126,882 | — | ↗ |
| 2021-04-22 | Emmitt Thomas K | Director / Officer | X-InTheMoney | A | Common Stock | 115,000 | 5.10 | 586.5K | 115,000 | — | ↗ |
| 2021-01-05 | Inter-M Traders FZ, LLE | 10% Owner | P-Purchase | A | Common Stock | 2,571,429 | 0.00 | — | 122,571,429 | — | ↗ |
| 2020-11-11 | Inter-M Traders FZ, LLE | 10% Owner | — | I | Series A Preferred Stock | 0 | 0.00 | — | 4 | — | ↗ |
| 2020-09-22 | Whitton Peter | Director | A-Award | A | Stock Option | 300,000 | 5.10 | 1.53M | 300,000 | — | ↗ |
| 2020-09-22 | Popolizio Aristotle | Director / Officer | A-Award | A | Stock Option | 300,000 | 2.50 | 750.0K | 300,000 | — | ↗ |
| 2020-09-22 | Emmitt Thomas K | Director / Officer | A-Award | A | Stock Option | 300,000 | 5.10 | 1.53M | 300,000 | — | ↗ |
| 2020-09-22 | Drakos Evripides | Director | A-Award | A | Stock Option | 300,000 | 2.50 | 750.0K | 300,000 | — | ↗ |
| 2020-07-31 | Whitton Peter | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-07-31 | Popolizio Aristotle | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-07-31 | Emmitt Thomas K | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-07-31 | Drakos Evripides | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-01-06 | Whitton Peter | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-01-06 | Popolizio Aristotle | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-01-06 | Drakos Evripides | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-07-31 | Emmitt Thomas K | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-07-31 | Cell Science Holding, Ltd. | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 210,000,000 | — | ↗ |
| 2018-05-16 | Oz Corp | 10% Owner | — | D | Common shares | 0 | 0.00 | — | 335,000 | — | ↗ |
Executive team
Top executives
Shares Outstanding
301.30M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Aristotle Popolizio | Executive Vice President, Secretary, & Director | 120.0K | male |
| Juan Carlos Garcia La Sienra Garcia | Chief Financial & Accounting Officer | 60.0K | male |
| Peter Whitton | Head of Science & Director | — | — |
| Teddy C. Scott | President & Chief Executive Officer | — | — |
ESG Rating
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BKUH
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
